Showing results (201-210 of 245) with videos related to

Sort By:
Pageof 25
Annals of Surgery|September 1, 2017
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study GroupBrett L Ecker, Matthew T McMillan, Valentina Allegrini, et al.
The British Journal of Surgery|April 8, 2020
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort studyA L Moekotte, G Malleo, S van Roessel, et al.
Nature|November 19, 2025
Hepatic zonation determines tumorigenic potential of mutant β-cateninAlexander Raven, Kathryn Gilroy, Hu Jin, et al.
Gut|September 27, 2023
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapyColm J O'Rourke, Massimiliano Salati, Colin Rae, et al.
Neurosurgical Focus|September 1, 2023
Three-level ACDF versus 3-level laminectomy and fusion: are there differences in outcomes? An analysis of the Quality Outcomes Database cervical spondylotic myelopathy cohortVardhaan S Ambati, Mohamed Macki, Andrew K Chan, et al.
Journal of Neurosurgery. Spine|February 28, 2025
Urinary control in cervical myelopathy: does it improve postsurgery? A Quality Outcomes Database studySaman Shabani, Raj Swaroop Lavadi, Nitin Agarwal, et al.
Communications Biology|February 4, 2021
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical associationVanessa Lakis, Rita T Lawlor, Felicity Newell, et al.
Nature Communications|November 19, 2021
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damagePietro Carotenuto, Francesco Amato, Andrea Lampis, et al.
Annals of Surgery|July 18, 2020
Precision Oncology in Surgery: Patient Selection for Operable Pancreatic CancerStephan B Dreyer, Mark Pinese, Nigel B Jamieson, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 29, 2024
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumorsKathryn A F Pennel, Phimmada Hatthakarnkul, Colin S Wood, et al.
Pageof 25